Skip to content
All tests

Your test, explained

5 min read

Thyroid Peroxidase Antibodies (TPO) Blood Test: The Autoimmune Thyroid Indicator

A highly precise quantitative measurement of autoantibodies directed against the thyroid peroxidase enzyme. It is the gold-standard biomarker for diagnosing Hashimoto's thyroiditis, identifying the autoimmune etiology of hypothyroidism, and assessing obstetric risks.

At a glance

Start with the details.

A price isn’t listed yet. Explore the guide below.

Sample
Blood (Serum)
Typical turnaround
2 - 3 days
Before your appointment

Your options, side by side

Compare retailer prices.

Find a listing that fits your needs. Review the details, then order with the retailer.

0 listings

No retailer listings yet.

Read the test guide or explore other tests in the directory.

Explore tests

Prices shown are listed test prices, not checkout totals. Expand a listing for supplied fees and its observation date. Check included measurements, collection requirements, and the performing lab before ordering.

Understand before you decide

The test, explained.

Overview

Thyroid dysfunction is rarely just a 'glandular' problem; in over 80% of hypothyroid cases in the developed world, it is an immune system error. Testing TSH without evaluating the immune system's role leaves the root cause completely unaddressed.

As a senior clinical endocrinologist and immunologist, I rely on the Thyroid Peroxidase (TPO) Antibodies test as the definitive diagnostic marker for autoimmune thyroid disease. Thyroid peroxidase is the crucial enzyme inside your thyroid gland responsible for utilizing iodine to synthesize thyroid hormones (T3 and T4). In conditions like Hashimoto's Thyroiditis, your immune system mistakenly identifies this enzyme as a foreign invader and produces targeted antibodies (anti-TPO) to destroy it. This blood test quantifies that autoimmune assault. Identifying the presence and titer (concentration) of these antibodies allows us to predict impending thyroid failure months or even years before your standard TSH levels become abnormal, shifting the paradigm from reactive treatment to proactive autoimmune management.

About this test

Advanced Clinical Diagnostic Utility of TPO Antibodies

To extract genuine clinical utility from this immunological marker, it must be viewed as a measure of active immune dysregulation rather than just a static thyroid parameter.

1. The Pathophysiology of Destruction (Hashimoto's)
  • The Enzymatic Siege: Thyroid peroxidase (TPO) sits on the apical membrane of thyroid follicular cells. When anti-TPO antibodies bind to this enzyme, they trigger a cascade of localized inflammation, complement activation, and lymphocyte infiltration. This slowly destroys the architecture of the thyroid gland. A high TPO antibody titer confirms that the patient's hypothyroidism is not due to iodine deficiency or pituitary failure, but is a targeted autoimmune destruction (Hashimoto's Thyroiditis).

2. The Predictive Power in Subclinical Hypothyroidism
  • Early Intervention Window: Many patients present with 'Subclinical Hypothyroidism'—where TSH is slightly elevated, but free T4 is still normal. If a patient in this state tests positive for high TPO antibodies, clinical data shows they progress to overt, clinical hypothyroidism at a rate of roughly 4-5% per year. Knowing this allows practitioners to intervene early, utilizing immunomodulatory protocols to potentially slow the glandular destruction.

3. The Obstetric and Fertility Implications
  • Pregnancy Complications: TPO antibodies are highly relevant in reproductive endocrinology. Women who are euthyroid (normal thyroid function) but positive for TPO antibodies carry a significantly higher independent risk for recurrent miscarriage, premature delivery, and the development of Postpartum Thyroiditis. The antibodies cross the placenta and can indicate a systemic inflammatory state hostile to fetal implantation.

When to discuss this test

You should prioritize this targeted immunological evaluation when:

  • You are experiencing the classic symptoms of hypothyroidism (profound fatigue, unexplained weight gain, severe cold intolerance, brain fog, and hair loss), regardless of whether your TSH is strictly 'out of range.'
  • You present with a goiter (a visibly enlarged, swollen thyroid gland in the front of your neck) or a sensation of a 'lump' in your throat.
  • You are a female planning a pregnancy or currently in your first trimester, and you have a personal or family history of autoimmune disease or unexplained fertility challenges.
  • You have been diagnosed with another autoimmune condition (such as Celiac Disease, Type 1 Diabetes, or Vitiligo), as autoimmune diseases frequently cluster together (Polyautoimmunity).

Who may benefit

This test is an absolute necessity for endocrinologists diagnosing the root cause of thyroid failure, obstetricians mitigating miscarriage risks in high-risk pregnancies, and functional medicine practitioners seeking to cool systemic inflammation before irreversible glandular destruction occurs.

How this test is used

  • Hashimoto's Thyroiditis (Autoimmune Hypothyroidism)
  • Graves' Disease (Autoimmune Hyperthyroidism - alongside TSI antibodies)
  • Postpartum Thyroiditis
  • Autoimmune Polyglandular Syndrome

Before your appointment

Plan your visit.

Fasting
Follow retailer guidance

How to prepare

  • Fasting Not Required: Unlike metabolic or circadian hormones (like glucose or cortisol), circulating IgG autoantibodies do not fluctuate significantly based on recent meals. You do not need to fast for a TPO antibody test.
  • Mandatory Biotin Washout (72 Hours): This is the single most critical preparation step. Modern laboratories use an Electrochemiluminescence Immunoassay (ECLIA) that relies on a streptavidin-biotin binding mechanism to measure TPO antibodies. High doses of supplemental Biotin (Vitamin B7)—commonly found in hair/skin/nail vitamins, B-complexes, and prenatal vitamins—will severely interfere with this assay, frequently causing falsely low or falsely negative results. You must discontinue all biotin supplements 72 hours prior to the blood draw.
  • Hormone Medication Continuity: If you are already taking Levothyroxine (Synthroid) or Armour Thyroid, you do not need to stop your medication for an antibody test. Autoantibody titers reflect the immune system's memory and activity, which are not acutely masked by taking exogenous thyroid hormone on the morning of the test.

Important considerations

The 'Healthy Positive' Phenomenon: It is clinically important to note that approximately 5% to 10% of the general healthy population (and an even higher percentage of elderly women) will test positive for TPO antibodies without ever developing clinical thyroid disease. A positive result must always be correlated with a patient's symptoms, a thyroid ultrasound, and a full thyroid hormone panel (TSH, Free T3, Free T4) to determine if active destruction is actually occurring.

Follow the instructions from your retailer and clinician. Information on this page is educational and does not replace individual medical advice.

See what to expect

Sample reports & resources.

Published examples and supporting files for this test.

No sample files are published for this test yet.

Looking for your own results? Open your reports dashboard

For a closer look

Sources & further reading.

Further reading

Recent Clinical Breakthroughs (2024-2026):

  • Lowering Intervention Thresholds in Pregnancy: Following a landmark 2024 multinational trial published in Thyroid, the American Thyroid Association radically updated guidelines for TPO-positive pregnant women. Even if a pregnant woman's TSH is considered 'normal' (e.g., 2.5 - 4.0 mIU/L), the presence of high TPO antibodies now formally warrants immediate low-dose Levothyroxine intervention to drastically reduce the risk of neurodevelopmental delays in the fetus and prevent spontaneous abortion.
  • IgG Subclass Profiling: Advanced 2025 immunology research has revealed that not all TPO antibodies are equally destructive. New highly specific assays have identified that an overabundance of the IgG4 subclass of TPO antibodies indicates a rapidly fibrosing variant of Hashimoto's (Riedel's thyroiditis spectrum). This allows clinicians to predict which patients will lose thyroid function in months versus decades.
  • Biotin Interference FDA Updates: In 2025, the FDA issued severe new guidance regarding assay interference. It was found that over 20% of 'cured' or 'negative' Hashimoto's diagnoses were entirely false, driven purely by the exploding popularity of mega-dose biotin gummies among women experiencing thyroid-induced hair loss. This cemented the mandatory 72-hour clinical washout protocol.

Sources